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Abstract
Background: The use of teledermoscopy in the diagnostic management of pre-cancerous and
cancerous skin lesions involves digital dermoscopic images transmitted over telecommunication
networks via email or web applications. Teledermoscopy may improve the accuracy in clinical
diagnoses of melanoma skin cancer if integrated into electronic medical records and made
available to rural communities, potentially leading to decreased morbidity and mortality.
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Objective and method: The purpose of this paper is to present a systematic review of evidence
on the use of teledermoscopy to improve the accuracy of skin lesion identification in adult
populations. The PRISMA method guided the development of this systematic review. A total of
seven scholarly databases were searched for articles published between the years of 2000 and
2015. All studies were critically appraised using the Rosswurm and Larrabee critique worksheet,
placed in a matrix for comparison evaluating internal and external validity and inspected for
homogeneity of findings.
Results: Sixteen articles met inclusion criteria for this review. A majority of the studies were
cross-sectional and non-experimental. Ten of the 16 focused on interobserver concordance and
diagnostic agreement between teledermoscopy and another comparator. Instrumentation in
conducting the studies showed inconsistency with reported results.
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Discussion: Higher level evidence is needed to support clinical application of teledermoscopy
for accuracy of diagnostic measurement in the treatment of pre-cancerous and cancerous skin
lesions in adults. Future research is needed to develop a standardized, reliable and valid
measurement tool for implementation in clinical practice.
Keywords
Teledermatology; telehealth; teledermoscopy; melanoma
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Background
Melanoma, which is the most common and dangerous of all skin cancers,1 is the most
common cancer of young adults under the age of 24.2 Melanoma rates have continued to rise
over the past 30 years. It is estimated that approximately 76,380 new melanomas will be
diagnosed in the United States by the end of 2016, with 10,130 cases expected to result in
mortality.3 The Skin Cancer Foundation reports that one person dies of melanoma every
hour.2 Even though melanoma accounts for less than 1% of skin cancers, it remains the
leading cause of skin cancer deaths. Melanoma care is expensive; total direct care cost
concomitant for malignant melanoma treatment in 2010 was $2.36 billion in the United
States and total treatment costs have increased from an annual average of $3.57 billion
between 2002 and 2006 to $8.075 billion between 2007 and 2011.4
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Prevention is key for melanoma care. Early detection and treatment has the potential to
decrease cost, population morbidity and mortality. The Surgeon General created a call to
action to prevent skin cancer determining it to be a major public health problem;5 and the
United States Preventive Services Task Force (USPSTF) recommends skin cancer screening.
6 Access to screening programmes can be limited for rural and underserved populations,
creating a need for innovative methods to implement screening programmes.
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Progress in the fight against melanoma includes multiple advances in technology for
screening and follow-up assessments. Using technology to screen for melanoma in rural
areas may be one potential resolution to the screening access issue. Teledermoscopy has
been used for screening. Two main types of teledermatology exist for identification of
cancerous skin lesions including: store-and-forward (SAF) technology; and videoconferencing (VC) or live interaction (LI). The difference between standard SAF versus
teledermoscopy is the addition of the dermoscopic lens – these attachments can be used with
standard digital cameras then images sent to a dermatologist (teledermoscopy) or a
smartphone (mobile teledermoscopy). Without the dermoscopic lens, a consultation using
macro images in considered a SAF teledermatology consultation. VC and LI are skin
examinations performed in real-time communication using two-way audio, webcam or
virtual conference rooms.7 Mobile teledermoscopy involves the use of high speed, wireless
or broadband network connections to mobile devices such as smartphones, digital cameras
or computers for follow-up of suspicious lesions to providers.8 This mobile factor can be
added to both SAF and VC teleconsultation. Therefore, the following research question has
been formulated: What is the evidence related to the use of teledermoscopy to improve the
accuracy of skin lesion identification in the adult population?
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Methods
The PRISMA method was used to develop this systematic review.9 A review of the literature
was conducted between 1 September 2015 and 31 October 2015 using EBCSO host, The
Cochrane Library, OVID, PubMed, CINAHL, Academic Search Complete and MEDLINE,
with limits set for the years 2000 through 2015. Specific keywords and word combinations
included: ‘teledermoscopy’, ‘teledermoscopy and skin lesions’, ‘teledermoscopy and adults’,
‘mobile teledermoscopy’, ‘mobile teledermoscopy and skin lesions’, ‘teledermoscopy and
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patient-performed’, ‘mobile teledermoscopy and accuracy’, ‘teledermoscopy and clinical
screening’ and ‘mobile teledermoscopy and clinical screening’. Both The Cochrane Library
and CINAHL database searches yielded no search results.
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The completed search yielded 423 articles with 119 duplicates eliminated. Thus, 304
abstracts were reviewed for inclusion with the following inclusion criteria: (1) adults 18
years of age or older, (2) adults with skin lesions, (3) mobile teledermoscopy and (4) patientperformed or clinical screening teledermoscopy. One author independently extracted and
reviewed the initial literature for inclusion, with accuracy confirmed by two additional
authors for selection bias purposes. Thirty-seven abstracts met the inclusion criteria and the
full-text articles were obtained. The Rosswurm and Larrabee critique worksheet was utilized
to screen each article to reduce bias, determine validity, interpret results and evaluate
applicability in clinic practice and future research.10 After critiquing the full-text articles, 21
articles were removed from this review due to failure in meeting inclusion criteria. Articles
eliminated included the following: 13 articles focused specifically on teledermatology with
no definition of teledermoscopy in the actual studies;11–23 three letters to the editor;24–26
two purely informational articles without defined study groups or methodologies;27,28 one
practice guideline from the American Telemedicine Association on the Practice Guidelines
for Teledermatology;29 one expert review which focused on distinguishing malignant
tumours from benign utilizing dermoscopy;30 and one article involving only text-messaging
as a form of early detection.31 Figure 1 summarizes this literature screening process.

Results
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A total of 16 articles remained for inclusion. Table 1 includes a description of each article
(in alphabetical order by first author last name), year of publication, country, type of
teledermoscopy used, type of measurement data and strengths and weaknesses of the study.
Similarities and differences were noted in overall approach for the included studies. Ten of
the 16 studies focused on some level of interobserver agreement or diagnostic concordance
when evaluating the accuracy of the lesion diagnosis between teledermatologists, clinical
dermatologists and general practitioners.32–41 Nine studies examined the comparison
between teledermoscopy and biopsy and histopathology.32,34,35,37–40,42,43 Two of these
stated that face-to-face evaluation was used to confirm lesion diagnosis,33,44 and one study
specifically stated that both lesion histopathology and face-to-face comparison were used to
confirm final diagnoses.38 Eight studies focused on the use of a mobile device to perform
teledermoscopy,32,36,38,41,42,44–46 yet only one included use of an actual mobile phone
application or web-application.32Three studies included the use of SAF teledermoscopy;
38,40,43 two studies relied on patient ability to perform skin self-examination when using
teledermoscopy;44,46 two explored the use of teledermoscopy as a triage system;38,40 and
two compared teledermoscopy to the asymmetry-colour rule.44,46 Piccolo et al. was the only
study found to mention the use of multiple colleagues with varying levels of experience in
dermoscopy in the evaluation of cancerous lesions.39
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Four studies reported on the clinical accuracy of diagnosis using teledermoscopy.35,44–46
Ishioka et al. conducted a 24-month case-controlled study of 64 cases to determine
agreement between the clinical specialist making the diagnosis in person and the clinician’s
diagnosis by examining data and images via teledermoscopy with the same two
dermatologists for pre-selection and post diagnosis.35 Results of this study demonstrated
agreement between in-person examinations and biopsy results, and between levels of
teledermoscopy and biopsy results. Janda et al. compared teledermoscopy to skin selfexamination using a randomized controlled trial design with 22 participants.46 The
intervention group utilized smartphones with a dermoscope attachment plus the asymmetrycolour variation rule and the control group used only the asymmetry-colour variation rule.
During skin self-examination, 107 lesions were identified and during clinical evaluation, 42
lesions were noted but there was no difference between groups. Börve et al. conducted a
prospective study for one year to compare teledermoscopy referral via smartphone to paperbased referrals.45 The sample of 772 patients referred with smartphone teledermoscopy, and
746 patients referred by a paper-based system were compared to face-to-face observations.
The teledermoscopy group showed 22.6% more referrals than the paper-based group and 35
invasive melanocytic melanomas were prioritized correctly. Manahan et al. used a
randomized controlled trial over a 3 month time frame (N=49, 309 lesions submitted) to
compare skin self-examination with mobile teledermoscopy compared to clinical skin
examination.44 Skin self-examination plus mobile teledermoscopy showed high sensitivity
and moderate specificity. The clinical skin evaluation submitted by mobile teledermoscopy
was highly sensitive and highly specific, indicating concordance with the clinical diagnosis
and telediagnosis.
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Diagnostic reliability
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Eight studies reported on the reliability of teledermoscopy for diagnosing skin lesions.
Piccolo et al. determined that telediagnosis of melanomas was correct at
rates of 95%, 77% and 52% at low, medium and high diagnostic difficulty and dependent on
the experience of the observer.39 Fabbrocini et al. studied 44 lesions and determined that
irregular pigmentation and regression structures had a higher frequency for diagnosis in
teledermoscopic observations34 but in all other criteria, face-to face observations were better.
Warshaw et al. reported no significant differences in accuracy rates between macro images
alone and macro plus polarized light dermoscopy, primary diagnoses and management plans.
43 Griffiths compared patients using images via teledermoscopy to assess diagnostic
accuracy of 660 lesions in a crosssectional study and reported that no melanomas were
misdiagnosed using a TeleDerm service;47 net cost savings of 50% were projected due to
decreased hospital admissions/routine referrals. Tan et al. reported concordance between
face-to-face diagnosis and teledermoscopy at 74% (285/ 385 lesions),40 and 74% (219/296
lesions) for two dermatologists performing both exams for each patient. Kroemer et al.
demonstrated strong agreement between clinical image tele-evaluation and teledermoscopy
with biopsy,42 differentiating benign from malignant (90%; k=0.84). Both methods were
equally high on sensitivity for all diagnostic categories and specificity for benign nonmelanocytic (97%) and melanocytic lesions (99%). Lamel et al. reported overall diagnostic
agreement between mobile phone images and TeleDerm consultation and high agreement
32,34,36,39,40,42,43,47
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between dermatologists.36 Börve et al. conducted a second study and concluded that there is
high interobserver agreement between face-to-face consultation and teledermoscopy.32
Feasibility
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Five studies reported on feasibility of using teledermoscopy for assessing skin lesions in
addition to clinical diagnostic accuracy. Di Stefani et al. demonstrated that it was feasible to
achieve clinical diagnostic accuracy with agreement between face-to-face and two remote
teledermatologists.33 Massone et al. completed two studies, the first of which examined the
feasibility to perform a melanoma screening using cell phone images versus dermoscope
images.37 They determined that the quality of cell phone images was poorer than the quality
of dermoscopic images. The second study by Massone et al. investigated the feasibility of a
SAF teledermoscopy triage system over a 24-month time frame.38 The image quality was
excellent and diagnostic accuracy among teleconsultants was excellent with malignant and
benign lesions being correctly diagnosed by teleconsultants. Wu et al. evaluated the
feasibility of mobile dermoscopy by patients, diagnostic concordance of teledermoscopy
with conventional office-based visits and patient’s receptiveness to teledermoscopy for
short-term monitoring of nevi.41 On 30 image pairs evaluated by the teledermatologists,
there was 97% agreement with the decision made by the clinical dermatologist and patients
were receptive to teledermoscopy. Finally, Ishioka et al. reported that a web-based
teledermoscopic diagnosis is feasible and could potentially meet the patient care access
needs in rural areas.35
Limitations
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In this systematic review, there is some potential for selection bias due to the limited number
of available abstracts found as a result of key term search criteria. Conclusions were
interpreted with caution due to the lack of randomized controlled trials performed or
accessible. Cost was not considered as part of this literature review due to lack of reporting.
Finally, the variance of instrumentation could contribute to outcome bias due to identified
lack of consistency with image capture and quality. Additional selection bias may exist due
to individual selection of suspicious lesions for skin self-examinations, restriction of lesion
selection, and only primary body areas selection (arms, legs, face, backs and shoulders) and
lack of blinding was not possible in several studies due to face-to-face examinations.
External validity is limited in some studies due to small sample sizes. In addition, lack of
diversity in sample population (primarily male) is a consideration for generalizability.
Finally, the potential for recall bias using the same dermatologists for teledermoscopic and
face-to-face diagnosis exists as well as the reliability and reproducibility could be dependent
upon the level of dermatological training and experience.
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Discussion
Teledermoscopy is an identified modality with both mobile patient skin self-examination and
diagnosis or monitoring via teledermatologist. The American Telemedicine Association has
recommendations for best practices that delineate appropriate image acquisition, storage
retrieval and transmission and image display.29 These include both technical and clinical
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specifications. However, practice guidelines for teledermatology have no current
recommendation for standard lesion comparison.29
The results of this review revealed varying types of instrumentation used to capture skin
lesion images. The majority of the studies focused on digital cameras with attachable
dermoscopic devices, while others were built-in mobile phone applications. This difference
between types of image capture and storage can alter the appearance of the lesion,
emphasizing a need for consistent use of valid and reliable instrumentation that maximizes
image quality and contributes to accuracy of image interpretation.
Future implications for research and practice
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There are significant gaps remaining in the research methodological approaches that have
been used to study teledermoscopy. There is a continued need for future comparative
effectiveness studies aiming to identify the premier method for image capture, storage, and
review so that evidence can be provided for clinical practice guidelines. A more immediate
clinical practice change could include the integration of teledermoscopic images into the
patient electronic medical record (EMR). Automatic inclusion of patient images in the
patient’s record would enhance efficiency of care and access to specialty care. Ensuring that
image data is easily retrievable for patients and providers would be consistent with the most
recent emphasis on meaningful use of electronic health records. This would require that both
acute and chronic care facilities have access to picture archiving and communication systems
(PACS), which are key to digital integration for diagnostic management. As EMRs continue
to transform into meaningful use stage 3, image technology advancement is an essential
focus for clinical practice.
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Conclusion
With the escalation of malignant melanoma diagnoses on a national level, access to care is
essential and should be placed as a high priority on legislative agendas. The ability to take
mobile diagnostic preventive screening to the community has proved to be effective, and
incorporating teledermoscopy for suspected cancerous lesions could improve access to care.
Teledermoscopic evaluation of potentially cancerous skin lesions can be useful in the
prevention, diagnosis, and treatment of malignant melanoma. Higher level evidence such as
randomized controlled trials, comparative effectiveness trials, and meta-analyses are needed
to build evidence for clinical practice changes in both the acute care and community settings.
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Figure 1.

The literature screening process.
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Patients referred via
TDS (474 female;
61.4%).

Sample

Mobile phone (Nokia N73 built-in
3.2 Mpix; Nokia), camera lens
pocket DS device (DermLite II PRO
HR; 3Gen LLC), storage JPEG
format, saved USB,

Clinical photos (Nikon Coolpix
4300); DS photos (image resolution
of 2272 × 1704 pixels) with DS
attachment (Heine Delta 20), post
24 months SAF with JPEG images.

Smartphones with DS attach-ment
and the asymmetry- colour variation
rule.

TeleDerm service; GP record patient
history & images in EMR.

Photo (SAF) Nikon 4500 Coolpix
camera post oil immersion or US
gel.

Photo (Model 990, Nikon); JPEG
images (resolution 2048 × 1536
pixels, 24-bit colour depth); stored
dig VD (Videocap, DS Medica)

Smartphone (iPhone 4, Apple);
customized DS attachment
(FotoFinder, Handyscope,
FotoFinder Systems GmbH); webbased TD platform (Tele- Dermis,
iDoc24, AB, & iPhone (iDoc24,
AB)

PHC-iDoc24 PRO (iDoc24 AB)
app, handheld DS compatible with
smartphone

Instrument/device

Author Manuscript

Summary of results.

• Tele-evaluation strong
agreementdifferentiating benign from
malignant
• Clinical image tele-evaluation superior to
TDS with 16 vs. 22 opposing cases

• 72% agreement b/n in-person diagnosis
and biopsy result
• 66% agreement b/n telediagnosis and
biopsy results
• Web-based diagnostic service feasible;
four false negatives

• Additional lesions noted by clinical skin
exam (N = 42)
• Both intervention and control groups
missed two lesions by SSE

• Patients discharged by GP post TDS
referral = 75%
• GPs identified 7 lesions with TDS referral
confirmed melanomas.
• No melanomas misdiagnosed using
TeleDerm service.

• FTF diagnosis correct (66%, p < 0.05)and
better observation detected.
• TDS did not show similar diagnostic
accuracy as FTF in teleconsultation.

• FTF and two TDs moderate agree-ment
(FTF 65 lesions clinically equivocal)
• TD 1 and TD2 requested DS evaluation
(18.1%, 13.5%)
• Two-step clinical and TD approach
recommended

• FTF diagnostic accuracy statistically
higher than TD 1 (p < 0.04), similar to TD
2.
• IO concordance moderate agreement.
• Image quality rated excellent/suffi- cient
by TDs in 94%/84% cases, respectively.

• Triage more reliable with TDS
• Waiting times receiving surgical treatment
shorter in TDS group (p < 0.001)
• Smartphone TDS faster mgmt for skin
cancer patients.

Key findings

Author Manuscript

Table 1.
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Randomized controlled trial

Cross-sectional; non-experi- mental, comparative

Cross-sectional, Non-experi-mental comparative

Cross-sectional; non-experi-mental, comparative

Cross-sectional; non-experi-mental, comparative

Cross-sectional, experimen-tal, repeated measures
trial

Manahan et al.,44 2015
1. Clinical accuracy of SSE
+mobile TDS vs CSE.
2. SSE instructions improve
accuracy.

Massone et al.,37 2007
Melanoma screening feasibility with
clinical and dermoscopic images via
cellular phone.

Massone et al.,38 2014
Feasibility of a SAF TD triage
system

Piccolo et al.,39 2000
Agreement b/n direct clinical
diagnosis vs. telediagnosis

Tan et al.,40 2010
TDS as triage tool for skin lesions

Warshaw et al.,43 2009
Accuracy of SAF TD vs. in-person
clinical diagnosis

Author Manuscript
Cross-Sectional design, non-experimental

Author Manuscript

Lamel et al.,36 2012
1. Mobile phone use for
diagnoses and mgmt in skin cancer
screening
2. Diagnosis/concordance b/n inperson & TD evaluations at
screening event.
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N = 542 (pigmented
lesions); male 96%;
female 4%

N = 200 (patients);
male 74; female
126 N = 49l
(lesions)

N = 40 (total
patients); male 21;
female 19 N = 43
(pigmented lesions)

N = 962 (lesions) N
= 690 (patients);
male 642; female
48

N = 18 (male 12,
female 6)

N = 58 (309
lesions), age 50–60
years

N = 86 (137 skin
lesions); male 36;
female 50

Sample

Macro images (Nikon Coolpix 4500
SL-I ring flash, (Nikon); PLD
images (Nikon Coolpix 4500 3Gen
DermLite lens (3Gen), DS image

Nikon D50 digital SLR cam; HP
Photosmart 912 or Canon Photoshot
G6 1/1.8” 7 megapixel CCD dig
cam, DS lighting unit (DermLite
Foto; 3Gen LLC) with macro
adapter for DS images (1600 × 1200
JPEG; 24-bit colour depth MoleMap
point of diagnosis software
(MoleMap).

FTF Dermoscope (Heine Delta 10,
Heine Optotechnik), dig cam DCS
460, Kodak), with Nikon body
(N90, Nikon). Storage (Digital ELM
TeleDerm Workstation, Vanguard
Imaging Ltd). Image size:
2036 × 3060 pixels RGB colour
mode (32 bit/pixel) PEG 511 × 768
pixels in RGB colour mode (24 bit/
pixel)

Clinical images taken with Canon
Powershot dig cam (Canon); DS
images (DermLite Photo; 3Gen
LLC) adjusted from MoleMax
System (Derma Medical Systems)
used (SAF)

Sony Ericsson K 750i (2 Mpix
camera); pocket DS device with 25
mm 10 × lens (DermLite II PRO HR
-3Gen, LLC); images 1632 × 1224
pixels JPEG format

iPhone, Handyscope FotoFinder DS
attachment (FotoFinder Systems
GmbH)

Mobile Google Android G1 (HTC
Corporation); 3.2 Mpix autofocus
cam; enabled with ClickDerm
(Click Diagnostics).

Transmitted VI via e-derm consult
GmbH)

Instrument/device

Author Manuscript

Design

• No significant differences in accuracy b/n
macro images alone and macro + PLD
• No significant differences in primary
diagnosis or mgmt plan

• FTF and TD concordance 74%
• FTF and TD consultation concord-anee (k
= 0.90 in all categories)
• TDS successful triage tool for patients
referred to lesion diagnosis clinic

• Concordance of observers:Telediagnosis
performed better than FTF.
• Melanomas diagnosed correctly (95%,
77% and 52%) at low, medium and high.
• TDS reliable technique for cancerous skin
lesion diagnosis

• Image quality TDS vs DS: 88% excellent
• Diagnostic accuracy among
teleconsultants: 94% excellent
• TD determined as suitable in triage of skin
cancer

• Two teleconsultants both agreed with FTF
diagnosis in 89% of cases
• Clinical image alone insufficient to
correctly diagnose skin lesions and
determine value of DS contribution

• SSE + Mobile TDS at 69% with one
lesion requiring follow-up
• CSE found additional 40 lesions on 25
participants
• Overall concordance with clinical
diagnosis and TDS show substantial
agreement

• Mobile phone technology yielded high
mgmt agreement b/n TD and in- person
evaluation
• Mgmt agreement b/n dermatologists high
• Primary diagnostic agreement b/n
dermatologists high

Key findings

Author Manuscript

Author(s), year/purpose
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Author Manuscript
N = 29; male 16;
female 18

• Patient receptivity: TD significantly higher
in agreement compared to negative attitude
toward TD(p < 0.01)
• Findings suggest TDS both feasible and
effective for short-term monitoring of
clinically atypical nevi

• Diagnostic accuracy of TDS inferior to
clinical dermatology
• Patient receptivity: TD significantly

(35-mm Minolta × 370 with Heine
dermphot lens attachment, (Heine);
35-mm kodachrome (Nikon Cool
Scan LS-4000ED, Konica Minolta)
Images (Nikon D90 SLR dig cam
with 60-mm Macro Nikkor lens with
derm attachment (Epilume; Canfield
Imaging Systems, Inc.); 1 by patient
with mobile DS (DermScope;
Canfield Imaging Systems, Inc.)
attached to mobile phone with 8Mpix cam (iPhone 4S; Apple, Inc.)
Standard & routing taken under
contact, polarized light with × 10
magnification.

Key findings

Instrument/device

Abbreviations listed in alphabetical order: AC = asymmetry-colour; b/n = between; CSE = clinical skin examination; DS = dermoscopic; EMR = electronic medical record; FTF = face-to-face; GP= General
Practitioner; IO = interobserver; mgmt = management; PLD = polarized light dermoscopy; PSL = pigmented skin lesions; SAF = store-and-forward; SSE = skin self-examination; TD = teledermatology;
TDS = teledermoscopy; TDs = teledermoscopists).

Prospective, cohort study

Author Manuscript

Wu et al.,41 2015
Feasibility, efficacy and receptivity
of TDS for atypical nevi monitoring

Sample

Author Manuscript

Design

Author Manuscript

Author(s), year/purpose
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